▶ Watch the full iGenics video review before deciding
Health Reviews Labs Verdict
"Does it work" only makes sense once you understand what AREDS-2 actually measured. iGenics matches the clinically validated doses and extends beyond them — this is the rare case where a supplement formula closely tracks the underlying science.
What Is the AREDS-2 Protocol?
The original Age-Related Eye Disease Study (AREDS) ran from 1992 to 2001 and was the first major trial to establish that nutritional supplementation could meaningfully affect eye health outcomes. AREDS-2, conducted from 2006 to 2012, refined the formula based on those results — most notably replacing beta-carotene (linked to lung cancer risk in smokers) with Lutein and Zeaxanthin.
The exact AREDS-2 protocol consists of: Lutein 10mg, Zeaxanthin 2mg, Vitamin C 500mg, Vitamin E 400 IU, Zinc 80mg (as zinc oxide), and Copper 2mg (as cupric oxide, to prevent copper deficiency from high zinc intake). This combination was tested on over 4,000 participants with intermediate AMD in a randomized, double-blind, placebo-controlled design — the gold standard of clinical research.
The Published Results
Published in JAMA Ophthalmology, the AREDS-2 trial found that participants taking the nutrient combination had a 25% lower risk of progressing to advanced AMD over five years compared to placebo. This is considered one of the most clinically significant findings in nutritional ophthalmology, and the formula is now recommended by the American Academy of Ophthalmology for patients with intermediate AMD.
iGenics vs. the AREDS-2 Protocol: Dose Comparison
Lutein: AREDS-2 calls for 10mg → iGenics provides 20mg
iGenics exceeds the studied dose, which some research suggests may provide additional macular pigment benefit, though the AREDS-2 trial itself only tested the 10mg level.
Zeaxanthin: AREDS-2 calls for 2mg → iGenics provides 2mg
Exact match to the clinically tested dose.
Vitamin C, E, Zinc, Copper → Present in iGenics formula
iGenics includes all four AREDS-2 core vitamins and minerals at supportive levels alongside the carotenoids.
Bilberry, Saffron, Ginkgo, Turmeric → Not in original AREDS-2
These are additions based on more recent, separate research into retinal blood flow and inflammation — they extend the formula but were not part of the original clinical trial.
What "Works" Actually Means Here
It's important to be precise about claims. "Works" in the AREDS-2 context means: reduces the statistical risk of progressing to advanced AMD by roughly a quarter, over a five-year period, in people who already have intermediate-stage disease. It does not mean reversing existing damage, and it does not mean preventing AMD entirely in someone with no signs of it. Within that defined scope, however, the evidence is unusually strong for a nutritional intervention.
See the Full AREDS-2-Based Formula
12 Ingredients · Doses Matched to Research · Vegan · Zero Fillers
→ Visit Official iGenics Website